JP2000503003A5 - - Google Patents

Download PDF

Info

Publication number: JP2000503003A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

JP1997523703A

Other languages

English (en)

Other versions

JP2000503003A (ja

Filing date

1996-12-20

Publication date

2004-11-04

1995-12-22 Priority claimed from US08/577,106 external-priority patent/US7354587B1/en

1996-12-20 Application filed filed Critical

1996-12-20 Priority claimed from PCT/US1996/019755 external-priority patent/WO1997023237A1/en

2000-03-14 Publication of JP2000503003A publication Critical patent/JP2000503003A/ja

2004-11-04 Publication of JP2000503003A5 publication Critical patent/JP2000503003A5/ja

Status Withdrawn legal-status Critical Current

Links

Description

JP09523703A 1995-12-22 1996-12-20 多段階カスケード増強ワクチンの効果を高めるための免疫接合体の使用 Withdrawn JP2000503003A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/577,106 US7354587B1 (en)	1994-07-06	1995-12-22	Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
US08/577,106		1995-12-22
PCT/US1996/019755 WO1997023237A1 (en)	1995-12-22	1996-12-20	Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2008016220A Division JP2008115196A (ja)	1995-12-22	2008-01-28	多段階カスケード増強ワクチンの効果を高めるための免疫接合体

Publications (2)

Publication Number	Publication Date
JP2000503003A JP2000503003A (ja)	2000-03-14
JP2000503003A5 true JP2000503003A5 (ja)	2004-11-04

Family

ID=24307306

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
JP09523703A Withdrawn JP2000503003A (ja)	1995-12-22	1996-12-20	多段階カスケード増強ワクチンの効果を高めるための免疫接合体の使用
JP2008016220A Pending JP2008115196A (ja)	1995-12-22	2008-01-28	多段階カスケード増強ワクチンの効果を高めるための免疫接合体

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
JP2008016220A Pending JP2008115196A (ja)	1995-12-22	2008-01-28	多段階カスケード増強ワクチンの効果を高めるための免疫接合体

Country Status (5)

Country	Link
EP (2)	EP2057999A3 (ja)
JP (2)	JP2000503003A (ja)
AU (1)	AU721927B2 (ja)
CA (1)	CA2240834C (ja)
WO (1)	WO1997023237A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100352511C (zh) *	1997-08-13	2007-12-05	Uab研究基金会	局部应用基因载体的疫苗接种
AU2994599A (en) *	1998-03-06	1999-09-20	Imclone Systems Incorporated	Active immunization against angiogenesis-associated antigens
ATE473242T1 (de)	1998-05-20	2010-07-15	Immunomedics Inc	Therapeutische mittel welche einen bispezifischen anti-hla class ii invariant chain x anti-pathogen antikörper enthalten
DE60042785D1 (de) *	1999-06-09	2009-10-01	Immunomedics Inc	Immuntherapie von autoimmunerkrankungen durch die verwendung von b-zell spezifischen antikörpern
EP1221961A4 (en) *	1999-10-13	2004-03-31	Roswell Park Memorial Inst	INDUCTION OF A STRONG IMMUNE RESPONSE TO A TUMOR-RELATED SELF-ANTIGEN
JP4212921B2 (ja)	2002-03-29	2009-01-21	独立行政法人科学技術振興機構	抗体を提示するタンパク質中空ナノ粒子を用いる治療薬剤およびタンパク質中空ナノ粒子
TWI434855B (zh) *	2006-11-21	2014-04-21	Hoffmann La Roche	結合物及其在免疫分析中作為參考標準之用途
MX2009012922A (es) *	2007-05-31	2010-07-05	Academisch Ziekenhuis Leiden H	Vacunacion intradermica de un peptido del virus del papiloma humano.
TWI438675B (zh)	2010-04-30	2014-05-21	Ibm	提供情境感知援助說明之方法、裝置及電腦程式產品
CN103561771B (zh)	2011-03-17	2019-01-04	伯明翰大学	重新定向的免疫治疗
GB201203442D0 (en)	2012-02-28	2012-04-11	Univ Birmingham	Immunotherapeutic molecules and uses
WO2013139789A1 (en) *	2012-03-19	2013-09-26	Deutsches Krebsforschungszentrum	B-cell receptor complex binding proteins containing t-cell epitopes
GB201216649D0 (en) *	2012-09-18	2012-10-31	Univ Birmingham	Agents and methods
US10441649B2 (en)	2015-02-02	2019-10-15	The University Of Birmingham	Targeting moiety peptide epitope complexes having a plurality of T-cell epitopes
FI3377103T4 (fi)	2015-11-19	2025-04-16	Revitope Limited	Funktionaalinen vasta-ainefragmenttikomplementointi kaksikomponenttiselle järjestelmälle epätoivottujen solujen uudelleenohjattua tappamista varten

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4036945A (en)	1976-05-03	1977-07-19	The Massachusetts General Hospital	Composition and method for determining the size and location of myocardial infarcts
US4361549A (en)	1979-04-26	1982-11-30	Ortho Pharmaceutical Corporation	Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4331647A (en)	1980-03-03	1982-05-25	Goldenberg Milton David	Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4671958A (en)	1982-03-09	1987-06-09	Cytogen Corporation	Antibody conjugates for the delivery of compounds to target sites
US4818709A (en)	1983-01-21	1989-04-04	Primus Frederick J	CEA-family antigens, Anti-CEA antibodies and CEA immunoassay
US5851526A (en) *	1985-04-19	1998-12-22	Ludwig Institute For Cancer Research	Methods of treating colon cancer utilizing tumor-specific antibodies
US5525338A (en)	1992-08-21	1996-06-11	Immunomedics, Inc.	Detection and therapy of lesions with biotin/avidin conjugates
US4699784A (en)	1986-02-25	1987-10-13	Center For Molecular Medicine & Immunology	Tumoricidal methotrexate-antibody conjugate
US5057313A (en)	1986-02-25	1991-10-15	The Center For Molecular Medicine And Immunology	Diagnostic and therapeutic antibody conjugates
US5194254A (en) *	1986-05-06	1993-03-16	Connaught Laboratories Limited	Enhancement of antigen immunogenicity
GB8610983D0 (en) *	1986-05-06	1986-06-11	Connaught Lab	Enhancement of antigen immunogenicity
US4946778A (en)	1987-09-21	1990-08-07	Genex Corporation	Single polypeptide chain binding molecules
DK8189A (da) *	1988-01-12	1989-07-13	Bunge Australia	Antigen-antistof-konjugater, deres fremstilling og anvendelse
EP0438803B1 (en)	1990-01-26	1997-03-12	Immunomedics, Inc.	Vaccines against cancer and infectious diseases
US5443953A (en)	1993-12-08	1995-08-22	Immunomedics, Inc.	Preparation and use of immunoconjugates
ATE204300T1 (de) *	1994-05-13	2001-09-15	Biovation Ltd	Zielzellen-bindende chimäre peptide
US5686578A (en) *	1994-08-05	1997-11-11	Immunomedics, Inc.	Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
WO1996040941A1 (en) *	1995-06-07	1996-12-19	Connaught Laboratories Limited	Chimeric antibodies for delivery of antigens to selected cells of the immune system

1996
- 1996-12-20 AU AU12871/97A patent/AU721927B2/en not_active Ceased
- 1996-12-20 EP EP09002533A patent/EP2057999A3/en not_active Ceased
- 1996-12-20 WO PCT/US1996/019755 patent/WO1997023237A1/en not_active Ceased
- 1996-12-20 EP EP96943706A patent/EP0881910A4/en not_active Ceased
- 1996-12-20 CA CA2240834A patent/CA2240834C/en not_active Expired - Fee Related
- 1996-12-20 JP JP09523703A patent/JP2000503003A/ja not_active Withdrawn
2008
- 2008-01-28 JP JP2008016220A patent/JP2008115196A/ja active Pending

Publication	Publication Date	Title
JP2000500445A5 (ja)	2004-10-14
JP2000500228A5 (ja)	2004-09-09
JP2000500033A5 (ja)	2004-09-09
JPH11510278A5 (ja)	2004-08-26
JP2000500440A5 (ja)	2004-10-21
JP2000500145A5 (ja)	2004-10-14
JP2000500155A5 (ja)	2004-10-21
JP2000502919A5 (ja)	2004-11-04
JP2000500406A5 (ja)	2004-10-14
JP2000500361A5 (ja)	2004-10-14
JP2000500115A5 (ja)	2004-07-08
JPH11510132A5 (ja)	2004-08-26
JP2000500342A5 (ja)	2004-10-21
JP2000500192A5 (ja)	2004-07-15
JP2000500112A5 (ja)	2004-10-14
JP2000500226A5 (ja)	2004-08-12
JP2000517360A5 (ja)	2004-11-18
JP2000500051A5 (ja)	2004-10-14
JP2000500166A5 (ja)	2004-09-24
JP2000500397A5 (ja)	2004-10-21
JP2000500407A5 (ja)	2004-10-21
JP2000500019A5 (ja)	2004-11-04
JPH11509055A5 (ja)	2004-08-19
JP2000500125A5 (ja)	2004-10-21
JP2000500346A5 (ja)	2005-06-16